We utilized it to explore the mRNA expression of ZSCAN20 and diverse immune subgroups in HCC, and we found that the expression of ZSCAN20 was higher in the C1 (wound healing) and C2 (IFN-γ dominant) subgroups, while the expression in the C6 (TGF-β dominant) subgroup was lower (Figure 9C). The gene discussed is IFNG; the disease is hepatocellular carcinoma.